Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
BMO Capital has lowered the price target on HCA Healthcare Inc (NYSE:HCA) to $250 from $275 while keeping the Market Perform rating on the shares after its Q4 results.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Analyst Matt Borsch notes execution was very strong, but HCA still contends with near-term issues that include uneven volumes, staffing constraints, and related wage and other inflation.
- The analyst also adds that the Q4 results are likely to continue to be volatile.
- Related: HCA Healthcare Q4 Earnings Lag Estimates, Issues FY22 Guidance.
- After the earnings, Cowen lowered the price target from $302 to $265 and kept an Outperform rating on the shares.
- The analyst updated his model by slightly lowering its EBITDA for 2022, 2023, and 2024 due to COVID costs/occupancy and deferred surgical recovery labor costs.
- Price Action: HCA shares are up 1.55% at $240.26 during the market session on the last check Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.